VKTX Viking Therapeutics, Inc.

Nasdaq vikingtherapeutics.com


$ 35.25 $ 0.29 (0.83 %)    

Wednesday, 29-Oct-2025 19:41:06 EDT
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 35.22
$ 35.45
$ 35.00 x 2
$ 36.00 x 100
$ 34.84 - $ 36.45
$ 18.92 - $ 79.10
3,894,501
na
3.98B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-22-2025 09-30-2025 10-Q
2 07-23-2025 06-30-2025 10-Q
3 04-24-2025 03-31-2025 10-Q
4 02-26-2025 01-01-1970 10-K
5 10-23-2024 09-30-2024 10-Q
6 07-24-2024 06-30-2024 10-Q
7 04-25-2024 03-31-2024 10-Q
8 02-07-2024 12-31-2023 10-K
9 10-25-2023 09-30-2023 10-Q
10 07-26-2023 06-30-2023 10-Q
11 04-26-2023 03-31-2023 10-Q
12 02-10-2023 12-31-2022 10-K
13 10-26-2022 09-30-2022 10-Q
14 07-27-2022 06-30-2022 10-Q
15 04-27-2022 03-31-2022 10-Q
16 02-09-2022 12-31-2021 10-K
17 11-03-2021 09-30-2021 10-Q
18 07-28-2021 06-30-2021 10-Q
19 04-28-2021 03-31-2021 10-Q
20 02-17-2021 12-31-2020 10-K
21 10-28-2020 09-30-2020 10-Q
22 07-29-2020 06-30-2020 10-Q
23 04-30-2020 03-31-2020 10-Q
24 02-26-2020 12-31-2019 10-K
25 11-05-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 03-13-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-07-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-21-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-11-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-08-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 viking-therapeutics-announces-that-its-vv2735-obesity-program-will-be-featured-in-two-poster-presentations-at-obesityweek-2025-in-atlanta

Poster Presentation on VENTURE Study Results Evaluating Impact of VK2735 on Prediabetes and Cardiometabolic StatusAdditional Po...

 canaccord-genuity-initiates-coverage-on-viking-therapeutics-with-buy-rating-announces-price-target-of-106

Canaccord Genuity analyst Edward Nash initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Buy rating and announce...

 jp-morgan-maintains-overweight-on-viking-therapeutics-lowers-price-target-to-75

JP Morgan analyst Hardik Parikh maintains Viking Therapeutics (NASDAQ:VKTX) with a Overweight and lowers the price target fr...

 why-is-viking-therapeutics-stock-rising-today

Viking Therapeutics shares are rising Thursday. The clinical-stage biopharmaceutical company reported third-quarter earnings an...

 morgan-stanley-maintains-overweight-on-viking-therapeutics-raises-price-target-to-102

Morgan Stanley analyst Michael Ulz maintains Viking Therapeutics (NASDAQ:VKTX) with a Overweight and raises the price target...

 viking-therapeutics-q3-eps-081-misses-072-estimate

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of...

 retail-investors-top-stocks-with-earnings-this-week-tesla-netflix-intel-and-more

Retail investors prepare for the first busy week in the Q3 earnings season, with Tesla, Netflix and Intel on deck.

 hc-wainwright--co-reiterates-buy-on-viking-therapeutics-maintains-102-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ: VKTX) with a Buy and maintains $102...

 btig-reiterates-buy-on-viking-therapeutics-maintains-125-price-target

BTIG analyst Justin Zelin reiterates Viking Therapeutics (NASDAQ:VKTX) with a Buy and maintains $125 price target.

Core News & Articles

https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingre...

 jim-cramer-expects-palantir-to-reach-new-all-time-high

Market analysts and financial commentators provide crucial guidance in the volatile investment landscape. Cramer says no to VKT...

 benzinga-bulls-and-bears-sunrun-newegg-walmart--and-powell-offers-rate-cut-hope

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

 vikings-42-plunge-splits-expertsa-129-strong-buy-or-clearly-inferior-drug

Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it&...

 palantir-amd-oracle-viking-and-nvidia-why-these-5-stocks-are-on-investors-radars-today

U.S. stock indices closed mixed on Tuesday, with the Dow Jones Industrial Average edging up 0.02% to 44,922.27.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION